Hunan Deruilai Biological Technology Co., Ltd.  

Product Name: Ligandrol 1165910-22-4 Lgd 4033 Drugs Sarms Bodybuilding Powder Lgd-4033 Model NO.: 1165910-22-4 Purity: >99% State: Solid Suitable for: Adult Certification: GMP, HSE, ISO 9001, USP, BP Customized: Non-Customized Powder: Yes Trademark: Dreilai Transport Package: Aluminum Foil Bag, Drum or Tin Specification: solid Origin: Hunan HS Code: 6809900000 Product Description Bodybuilding Sarms powder Lgd-4033 Lgd 4033 Ligandrol 1165910-22-4Product Name:Ligandrol PowderOther Name:LGD 4033Purity:98%min by HPLCCAS No.:1165910-22-4Appearance: White fine powderM.W.:441.36Melting Point:105-107ºCM.F.:C14H12F6N2ODensity:1.472g/cm3Solubility: DMSOProduct DescriptionLGD-4033 is a selective androgen receptor modulator (SARMS), and a novel non-steroidal SARM that binds to AR with high affinity (Ki of ~1 nM) and selectivity. It's in a class of androgen receptor (AR) ligands that is tissue selective, developed to treat muscle wasting associated with cancer, acute and chronic illness and age-related muscle loss. LGD-4033 is expected to produce the therapeutic benefits with improved safety, tolerability and patient acceptance due to tissue-selective mechanism of action and an route of administration.Product Name:LGD-4033Synonyms:4-((R)-2-((R)-2,2,2-trifluoro-1-hydroxyethyl)pyrrolidin-1-yl)-2-trifluoroMethyl)benzonitrile(LGD-4033);LGD-4033;4-[(2R)-2-[(1R)-2,2,2-Trifluoro-1-hydroxyethyl]-1-pyrrolidinyl]-2-(trifluoromethyl)benzonitrile;4-((R)-2-((R)-2,2,2-Trifluoro-1-hydroxyethyl)pyrrolidin-1-yl)-2-trifluoroMethyl)benzonitrile;LIGANDROL;4-[(2R)-2-[(1R)-2,2,2-trifluoro-1-hydroxyethyl]pyrrolidin-1-yl]-2-(trifluoromethyl)benzonitrileCAS:1165910-22-4Function.LGD4033 works by tying androgen receptors selectively. It shows anabolic activity in the bones and muscles instead of harmfully affecting the prostate and sebaceous glands which usually happens when using steroids. LGD-4033 just concluded a study called Phase I Multiple Ascending Dose which included fit volunteers. This was an unplanned, double bind analysis stage that included a placebo.Effects similar to anabolics with size and strength1Minimal Side Effects2 Excellent for recomping3Healing properties4 Prevents muscle wastingWorks well as a stand alone or stacked with other SARMSOther SARMsNameCAS NO.UsageAICAR2627-69-2acts by entering nucleoside pools, significantly increasing levels of adenosineduring periods of ATP breakdownMK2866841205-47-8medical prescription for prevention of cachexia, atrophy, and sarcopenia andfor Hormone or Testoserone Replacement Therapy.MK-67715972-10-0for the treatment of frailty in the elderlyLGD-40331165910-22-4pharmacological profile similar to that of enobosarm, Ostarine,MK-2866GW1516317318-70-0For obesity, diabetes, dyslipidemia and cardiovascular diseaseAndarine(S4)401900-40-0partial agonist, intended mainly for treatment of benign prostatic hypertrophySR90091379686-30-2under development at The Scripps Research Institute (TSRI),increases the level of metabolic activity in skeletal muscles of miceRAD1401182367-47-0New generation for gaining mass and cutting edgesYK11431579-34-9YK11: aSARM and myostatin inhibitor in oneAC262356870888-46-3New SARMSSR90111379686-29-9New SARMSS231010396-29-8New SARMSGW0724317318-84-6New SARMS